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Human RTEL1 is an essential, multifunctional heli-
case that maintains telomeres, regulates homolo-
gous recombination, and helps prevent bonemarrow
failure. Here, we show that RTEL1 also blocks trinu-
cleotide repeat expansions, the causal mutation for
17 neurological diseases. Increased expansion fre-
quencies of (CTG,CAG) repeats occurred in human
cells following knockdown of RTEL1, but not the
alternative helicase Fbh1, and purified RTEL1 effi-
ciently unwound triplet repeat hairpins in vitro. The
expansion-blocking activity of RTEL1 also required
Rad18 and HLTF, homologs of yeast Rad18 and
Rad5. These findings are reminiscent of budding
yeast Srs2, which inhibits expansions, unwinds hair-
pins, and prevents triplet-repeat-induced chromo-
some fragility. Accordingly, we found expansions
and fragility were suppressed in yeast srs2 mutants
expressing RTEL1, but not Fbh1. We propose that
RTEL1 serves as a human analog of Srs2 to inhibit
(CTG,CAG) repeat expansions and fragility, likely
by unwinding problematic hairpins.
INTRODUCTION
Expansions of trinucleotide repeats (TNRs) are the causative
mutations in 17 human neurological disorders, including Hun-
tington’s disease and fragile X syndrome (Lo´pez Castel et al.,
2010; McMurray, 2010; Mirkin, 2007). Although complex molec-
ular mechanisms drive expansions (Lo´pez Castel et al., 2010;
McMurray, 2010; Mirkin, 2007), it is clear that two categories of
protein factors are crucial in determining whether an expansion
occurs. Promutagenic factors favor the expansion process,
relentlessly driving TNRs toward longer allele lengths. Antimuta-
genic proteins inhibit the expansion process and are important in
helping prevent the initiating expansions that trigger instability.Both categories of proteins likely act on aberrant DNA secondary
structures, such as hairpins, that are widely thought to be inter-
mediates in the expansion process (Liu et al., 2010; Lo´pez Castel
et al., 2010; McMurray, 2010; Mirkin, 2007). One of the most
pressing issues is to identify human factors in both categories
and determine how they regulate the enigmatic expansion pro-
cess. In this study, we sought human proteins that inhibit expan-
sions by examining model organisms for inhibitory factors that
have human counterparts.
Studies in budding yeast identified the helicase Srs2 as a key
protein for inhibiting TNR expansions. The likelihood of an
expansion is increased up to 40-fold in srs2 mutants (Bhatta-
charyya and Lahue, 2004; Daee et al., 2007; Kerrest et al.,
2009). In contrast, mutation of a related helicase gene, SGS1,
did not recapitulate the expansion defects of srs2 mutants
(Bhattacharyya and Lahue, 2004; Kerrest et al., 2009). In one
study, Srs2 was shown to function with the error-free branch of
postreplication repair (PRR) (Daee et al., 2007). Mutants in PRR
genes RAD5 or RAD18 also showed higher rates of expansion,
and double-mutant analysis was consistent with an epistatic
relationship between SRS2 and PRR genes. In vitro, purified
Srs2 enzyme was particularly effective at unwinding a number
of TNR hairpin structures, which are thought to be key inter-
mediates in the expansion process (Anand et al., 2012; Bhatta-
charyya and Lahue, 2005; Dhar and Lahue, 2008). In vivo,
ATPase-defective alleles of srs2 were also deficient at blocking
expansions (Bhattacharyya and Lahue, 2004) and in facilitating
replication through CGG repeats (Anand et al., 2012). Thus,
Srs2 most likely inhibits expansions by unwinding TNR hairpins,
precluding their further processing into the full expansion
mutation. This antiexpansion activity of Srs2 is in addition to its
better-known role as a negative regulator of homologous
recombination (HR) (Karpenshif and Bernstein, 2012; Marini
and Krejci, 2010). During HR, Srs2 disassembles Rad51-sin-
gle-stranded DNA filaments to prevent toxic recombination
(Krejci et al., 2003; Veaute et al., 2003). Mutants of SRS2 are
synthetically lethal when combined with SGS1 defects due to
uncontrolled levels of recombination (Gangloff et al., 2000).
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preventing TNR instability for long disease-length alleles, which
are prone to breakage. Srs2 achieves this role by controlling
sister-chromatid recombination initiated by repeat-associated
fork blockage or breaks (Anand et al., 2012; Kerrest et al.,
2009). Thus, Srs2 makes a major contribution to genomic stabil-
ity by inhibiting TNR expansions both via hairpin unwinding and
by blocking excessive HR.
Despite the absence of sequence homologs of yeast Srs2
protein in metazoan organisms, several helicases have functions
analogous to Srs2 (Karpenshif and Bernstein, 2012; Uringa et al.,
2011). Some functions of the essential helicase RTEL1 parallel
those of Srs2 (Uringa et al., 2011). RTEL1 negatively regulates
HR (Barber et al., 2008; Uringa et al., 2012), and RTEL1 is a
helicase capable of unwinding unusual DNA structures in vitro
(Vannier et al., 2012). Furthermore, rtel1 mutants in C. elegans
are synthetically lethal when combined with mutation of HIM-6,
the invertebrate homolog of yeast SGS1 (Barber et al., 2008).
Inherited mutations in RTEL1 cause Hoyeraal-Hreidarsson
syndrome, a severe form of dyskeratosis congenita that leads
to early bone marrow failure (Ballew et al., 2013; Le Guen
et al., 2013; Walne et al., 2013). A second protein with functions
analogous to Srs2 is Fbh1, a human helicase/F-box protein
(Kim et al., 2002). Fission yeast Fbh1 regulates recombination
(Morishita et al., 2005; Osman et al., 2005). Human Fbh1 ex-
pressed in budding yeast suppressed recombination defects
of srs2 mutants and rescued the methylmethanesulfonate
(MMS) sensitivity of rad18 or rad5 mutants in the presence of
srs2 (Chiolo et al., 2007). A third analog, PARI, inhibits recom-
bination and stabilizes the genome in a manner requiring prolif-
erating cell nuclear antigen interaction (Moldovan et al., 2012).
Unlike Srs2, PARI does not appear to be an active helicase
and little is known about its in vivo function.
The goal of this study was to determine whether RTEL1 or
Fbh1 inhibits TNR expansions and fragility. Our evidence sup-
ports RTEL1, not Fbh1, as an inhibitor of expansions in human
cells and repeat-mediated chromosome fragility in budding
yeast. Furthermore, the data suggest RTEL1 acts as a helicase
to unwind TNR hairpins and thereby preclude the expansion
process.
RESULTS
RTEL1 Inhibits Expansions and Unwinds TNR Hairpins
If either RTEL1 or Fbh1 inhibits expansions in human cells, then
knockdown of the relevant factor should cause higher expansion
frequencies. To assess RTEL1 and Fbh1 activity toward expan-
sions, we combined small interfering RNA (siRNA) treatment
with a previously described TNR expansion assay (Experimental
Procedures; Figure S1). A human astrocytic cell line, SVG-A,
was used because these cells support expansions in culture
(Debacker et al., 2012; Gannon et al., 2012) and because in vivo
expansions occur in glia (Shelbourne et al., 2007). Knockdown
of Fbh1 in SVG-A cells produced virtually no change (<8%) in
expansion frequencies (Figure 1A). In contrast, knockdown of
RTEL1 increased expansions by 5- to 7-fold. This finding held
for pooled siRNA and two unique interfering RNAs (Figure 1A).
Knockdown efficiencies, measured by quantitative RT-PCR,
showed Fbh1 was reduced by 68% (±1%) and RTEL1 was828 Cell Reports 6, 827–835, March 13, 2014 ª2014 The Authorsreduced by 55% (±4%) by pooled siRNA and 69% (±13%) by
individual RNA #9 (Figure 1B). Although we cannot rule out that
residual Fbh1 levels might inhibit expansions, it is clear that
reducing RTEL1 mRNA levels by 55%–70% causes a pro-
nounced effect on expansions. From these assays, we conclude
that RTEL1 predominates at inhibiting expansions in this system.
Yeast Srs2 removes most TNR hairpins rather than acting
selectively on a subset of hairpin sizes, based on the finding
that mutation of SRS2 increases the rate of expansions without
detectably changing their size distribution (Bhattacharyya and
Lahue, 2004; Daee et al., 2007). To assess the expansion-block-
ing activity of human RTEL1, we examined expansion sizes
(Figure S1D). There was virtually no difference in expansion sizes
between scrambled control and siRNA against RTEL1. The
range of expansions (+4 to +20 repeats), weighted average
(+10.9 repeats), andmedian (+10 to +11 repeats) were extremely
similar. Final allele sizes up to 42 CTG,CAG repeats were
observed; thus, a subset of expansions that are inhibited by
RTEL1 would cross the disease threshold of 30–40 repeats
seen in some human neurological disorders.
Both yeast Srs2 and humanRTEL1 are DNA helicases. Several
lines of evidence suggest that the helicase function of Srs2 is
critical for inhibiting expansions. An ATPase mutant of Srs2,
K41A, is defective in blocking expansions in yeast (Bhattachar-
yya and Lahue, 2004), and a similar mutant, K41R, is defective
in facilitating replication through a CGG hairpin (Anand et al.,
2012). Purified Srs2 efficiently unwinds TNR hairpins of different
sizes and sequences (Bhattacharyya and Lahue, 2005; Dhar and
Lahue, 2008). Similarly, the K48R ATPase mutant of RTEL1 fails
to disassemble T-loops in cell-free extracts (Vannier et al., 2012).
We extended this analysis by performing helicase assays on a
TNR hairpin substrate with wild-type or K48R RTEL1. A duplex
molecule containing a (CTG)11 hairpin was chosen to mimic
a presumptive intermediate in the expansion process and
because +11 repeat expansions lie in the midrange of RTEL1
activity based on the size spectra described above. In vitro,
the wild-type enzyme, but not the mutant protein, efficiently un-
wound the (CTG)11 hairpin (Figures 1C and S2A). Unwinding by
wild-type RTEL1 occurred efficiently in the presence of MgCl2
and was inhibited by CaCl2, suggesting that helicase activity
requires Mg2+ as a cofactor (Figure S2B). RTEL1 was also effec-
tive on a substrate with extrahelical CAG repeats. A (CAG)11
substrate was efficiently unwound by wild-type RTEL1, but not
the K48R variant (Figure 1D). In summary, the helicase assays
are consistent with the notion that RTEL1 inhibits expansions
by unwinding TNR hairpins.
RTEL1 Functions with HLTF and Rad18 to Inhibit
Expansions
We also addressed whether additional factors work in conjunc-
tion with RTEL1 to inhibit expansions. One previous study of
yeast Srs2 (Daee et al., 2007) indicates that the enzyme blocks
expansions in concert with Rad5 and Rad18, proteins of the
error-free branch of PRR (Daee et al., 2007). We evaluated
the human homologs of these factors following depletion by
siRNA. Of the two reported orthologs of Rad5 (Lin et al., 2011;
Motegi et al., 2006; Unk et al., 2006), knockdown of HLTF,
but not SHPRH, raised expansion frequencies by 3- to 4-fold
Figure 1. RTEL1 Inhibits Expansions in Cells and Unwinds Hairpins
In Vitro
(A) Expansion frequencies after siRNA treatment. ‘‘RTEL1’’ denotes pooled
siRNA, whereas ‘‘RTEL1 #9’’ and ‘‘RTEL1 #7’’ designate unique siRNAs.(Figures 2A and 2B). Similarly, expansions were 4- to 5-fold more
common upon siRNA treatment against human Rad18 (Figures
2A and 2B). Thus, single knockdown of RTEL1, HLTF, or
Rad18 all conferred increases in expansion frequencies to
similar extents, consistent with a concerted mode of action.
Epistasis between RTEL1 and HLTF and between RTEL1 and
Rad18 was evaluated by double-knockdown assays. In each
case, expansions occurred about six times more frequently
than control levels (Figure 2B), although the magnitude of this
effect was not statistically different from the knockdown of any
single component alone (Figures 2B and S1E). In summary,
expansion assays in human cells suggests that RTEL1, not
Fbh1, is the functional equivalent of Srs2 in vertebrates and
that RTEL1 may function with HLTF and Rad18 to inhibit
expansions.
Efficacious knockdown occurred for HLTF (87% ± 5%),
SHPRH (75% ± 5%), and Rad18 (86% ± 9%) (Figures 2 and
S3A). Other studies reported that knockdown of SHPRH to
similar levels as seen here showed several phenotypes (Lin
et al., 2011; Motegi et al., 2006). Thus, the lack of an expansion
phenotype in our assays upon SHPRH knockdown is unlikely
due to residual levels of the protein. Similar knockdown effi-
ciency and specificity was seen upon double knockdowns of
HLTF (84% ± 3%), Rad18 (81% ± 3%), and RTEL1 (59%–71%;
Figures 2, S3B, and S3C).
Likewise, single knockdowns of HLTF or Rad18 yielded nearly
identical expansion size results to control or RTEL1 knockdowns
(Figure S1D), again consistent with coordination between RTEL1
and PRR enzymes. Expansion sizes were also similar in double
knockdowns of RTEL1+HLTF or RTEL1+Rad18, although the
size range was somewhat narrower and the weighted average
and median values were slightly lower than comparable single
knockdowns. Overall, we conclude that RTEL1, HLTF, and
Rad18may function coordinately to block most TNR expansions
in this system and thereby control the incidence of expansions,
not their sizes.
RTEL1 Suppresses MMS Sensitivity and Triplet
Repeat-Mediated Chromosome Fragility
and Expansions of Yeast srs2Mutants
If RTEL1 or Fbh1 is an analog of Srs2, then expressing these
human helicases in budding yeast might reverse srs2 pheno-
types. The human RTEL1 and FBH1 genes were integrated
into the SRS2 locus, thereby inactivating the yeast gene and
permitting expression of the human genes from the endogenous
SRS2 promoter (Figure S4A). Cells lacking Srs2 are moderately
sensitive to the cytotoxic effects of MMS (Chiolo et al., 2007).
The MMS sensitivity of the srs2D mutant was strongly sup-
pressed by expression of RTEL1 but only weakly suppressed
by Fbh1 (Figure 3A), suggesting that RTEL1 is the betterExpansion frequencies are normalized to those observed with scrambled
control siRNA. See Figure S1E for details.
(B) Knockdown efficiency based onmRNA levels, as measured by quantitative
RT-PCR. For (A) and (B), ‘‘Scr’’ denotes scrambled control siRNA and error
bars represent SEM. *p < 0.05 compared to scrambled control.
(C and D) Unwinding of (CTG)11 hairpin (C) or (CAG)11 hairpin (D) by purified
wild-type RTEL1 or K48R mutant RTEL1.
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Figure 2. Expansions in SVG-A Cells following Knockdowns of
RTEL1, HLTF, SHPRH, and Rad18
(A) Expansion frequencies for single knockdowns of HLTF, SHPRH, or Rad18
and immunoblot analysis of protein levels.
(B) Expansion frequencies following single or double knockdowns of RTEL1,
HLTF, or Rad18 and immunoblot results of protein levels.
*p < 0.05 compared to scrambled control, and error bars represent SEM.
Additional expression results are in Figure S3. See Figure S1E for details.
830 Cell Reports 6, 827–835, March 13, 2014 ª2014 The Authorssubstitute for Srs2. The genetic interaction of the helicases with
Rad5 was also examined because Rad5 is needed for the error-
free branch of PRR (Smirnova and Klein, 2003). rad5D mutants
are exquisitely sensitive to MMS, in part because Srs2 restrains
recombination. This hypersensitivity can be partly overcome in
an srs2D rad5D double mutant, because deletion of Srs2 is
thought to promote HR and therefore bypass the requirement
for Rad5 (Schiestl et al., 1990; Ulrich, 2001). This leads to the
prediction that MMS hypersensitivity should be restored in an
srs2D rad5D double mutant upon expression of a human analog
of Srs2. We found that expression of RTEL1 conferred extreme
MMS sensitivity to the double mutant, whereas Fbh1 did not
(Figure 3B). Thus, RTEL1, but not Fbh1, can substitute for the
role of Srs2 in the Rad5 branch of the PRR pathway in yeast.
The yeast strains expressing RTEL1 or Fbh1 were also tested
for triplet-repeat-mediated chromosomal fragility and instability.
Long TNR tracts, such as (CAG)70, undergo chromosome
fragility in yeast (Anand et al., 2012; Callahan et al., 2003; Freu-
denreich et al., 1998; Kerrest et al., 2009). DNA breaks are
prevented by Srs2, based on the finding that srs2 mutants
show increased levels of chromosome fragility (Anand et al.,
2012; Kerrest et al., 2009). Protection against chromosome
fragility was attributed to its function as a helicase that unwinds
hairpins encountered during replication (Anand et al., 2012) and/
or to a role in promoting fork reversal (Kerrest et al., 2009). We
found that chromosome fragility in the control strain lacking a
repeat tract was unchanged in the srs2Dmutant and expression
of Fbh1 or RTEL1 caused modest increases in breakage rates
(Figures 3C and S4B). The presence of the (CAG)70 tract resulted
in higher levels of breakage in the wild-type strain, an effect that
is exacerbated by the srs2D mutation, in agreement with previ-
ous studies (Anand et al., 2012; Kerrest et al., 2009). Expression
of Fbh1 did not detectably alter fragility rates compared to the
srs2D strain, whereas expression of RTEL1 conferred complete
rescue (Figures 3C and S4B). The fragility data suggest that
RTEL1 can substitute for Srs2 in facilitating replication through
TNRs. We also examined expansion frequencies for a (CAG)85
tract (Figures 3D and S4C). The srs2D strain showed 5-fold
more expansions than the wild-type control, similar to published
values (Kerrest et al., 2009). Expression of RTEL1 reduced
expansion levels to levels similar to wild-type. In contrast, the
expansion frequency was still partly elevated following expres-
sion of Fbh1. The partial rescue of (CAG)85 expansions by
Fbh1 is consistent with its known role in preventing recombina-
tion (Chiolo et al., 2007), because expansions of this repeat
size occur during a Rad51-dependent process in srs2D yeast
(Kerrest et al., 2009). Similarly, both Fbh1 and RTEL1 were
able to rescue the sensitivity of the srs2D strain to camptothecin
(Figure S4D). These two rescue phenotypes of Fbh1 prove that
Figure 3. Expression of RTEL1 in Yeast Sup-
presses srs2 Phenotypes
(A) Human RTEL1 (hRTEL1) can complement Srs2
and rescue srs2D sensitivity to MMS more effec-
tively than hFbh1.
(B) hRTEL1, but not hFbh1, expression in rad5D
mutants restores hypersensitivity to MMS.
(C) Chromosome fragility on a yeast artificial
chromosome (YAC) carrying a (CAG)70 tract
(Kerrest et al., 2009). Rate values indicated above
the bars; error bars represent SEM. Significance
was determined compared towild-type (*) or srs2D
(y). *p % 0.05, **p % 0.001. See Figure S4B for
details.
(D) Expansions of a (CAG)85 tract integrated on a
YAC. See Figure S4C for details.
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the protein is expressed in yeast, thereby eliminating the possi-
bility that failure of Fbh1 to rescue other srs2 phenotypes is due
to insufficient expression. Thus, although both helicases can
compensate for some Srs2 antirecombinase functions, RTEL1
is uniquely able to complement Srs2 roles in replication and
postreplication repair, based on the RTEL1 rescue of srs2D
MMS sensitivity, restoration of MMS hypersensitivity in a
rad5D background, and rescue of CAG repeat-mediated fragility
and instability in a srs2D mutant. We conclude that expression
of RTEL1 in yeast provides similar biochemical functions as
Srs2 in DNA repair and in inhibiting triplet-repeat-mediated
chromosome fragility and expansions.
DISCUSSION
Parallels between RTEL1 and Yeast Srs2 in Inhibiting
TNR Expansions and Fragility
This work identifies RTEL1 as a key human enzyme that inhibits
TNR expansions and fragility. Knockdown of RTEL1 in SVG-A
astrocytes caused a substantial increase in expansion fre-
quencies, whereas targeting Fbh1 conferred little effect (Fig-
ure 1A). Purified RTEL1 readily unwound CTG and CAG hairpin
structures in vitro, in a manner dependent on its ATPase activity
(Figures 1C and 1D). Similar increases in expansions were also
observed upon knockdown of Rad18 or the Rad5 ortholog
HLTF, and double knockdowns of RTEL1 with Rad18 or HLTF
are suggestive of a single pathway for inhibiting expansions (Fig-
ure 2). Our expansion results reveal a clear delineation between
the Rad5 orthologs HLTF and SHPRH, consistent with the
findings of Lin et al., who identified distinct functions for the
two enzymes in suppressing damage-induced mutagenesis
(Lin et al., 2011). These RTEL1 findings—inhibition of expan-
sions, hairpin unwinding, and function with the Rad5 ortholog
HLTF and Rad18—all closely resemble yeast Srs2, indicating
the strong functional conservation between the two enzymes
with respect to (CTG,CAG) repeat expansions, despite their
lack of protein sequence homology. We note that mutations in
yeast SRS2, RAD5, or RAD18 have different mutagenic effects
depending on the type of microsatellite (Cherng et al., 2011;
Daee et al., 2007; Shishkin et al., 2009), perhaps due to
the different DNA structures they can adopt (Mirkin, 2007). We
found expression of RTEL1 in yeast srs2 mutants efficiently
suppressed MMS sensitivity and CAG-repeat-dependent
chromosomal fragility and expansions, whereas expression of
Fbh1 was substantially poorer in reversing these phenotypes
(Figure 3). We conclude that RTEL1 is an important human factor
that blocks triplet repeat expansions and repeat-mediated
chromosome fragility and that its DNA helicase function is likely
important in doing so.
In contrast, we found little or no evidence for a role in triplet
repeat instability for the alternative Srs2 analog Fbh1. Fbh1
was originally identified as a human helicase/F-box protein
(Kim et al., 2002) and in fission yeast as a regulator of recom-
bination (Morishita et al., 2005; Osman et al., 2005). Fbh1 was
subsequently shown to function at replication forks (Lorenz
et al., 2009). A previous study showed that human Fbh1 ex-
pressed in budding yeast suppressed recombination defects
and MMS sensitivity of an srs2D mutant; however, Fbh1 did832 Cell Reports 6, 827–835, March 13, 2014 ª2014 The Authorsnot restore MMS hypersensitivity to a rad5D srs2D double
mutant (Chiolo et al., 2007), in agreement with our data (Fig-
ure 3B). Despite some parallels to Srs2, our experiments showed
no detectable role for Fbh1 at triplet repeats in SVG-A cells
(Figure 1A) and little evidence in yeast (Figure 3). Although we
cannot rigorously rule out that Fbh1 imparts protection at
TNRs in human cells, the current data do not support this
hypothesis.
Potential Mechanism of TNR Stabilization by RTEL1
Srs2 has been proposed to inhibit expansions through its heli-
case activity on TNR hairpins (Bhattacharyya and Lahue, 2004,
2005; Daee et al., 2007; Dhar and Lahue, 2008) and/or by
unwinding TNR structures to facilitate passage of replication
forks (Anand et al., 2012; Kerrest et al., 2009). Purified RTEL1
is capable of efficiently unwinding (CTG)11 and (CAG)11 hairpins
(Figures 1C and 1D), analogous to Srs2 (Bhattacharyya and
Lahue, 2005; Dhar and Lahue, 2008). The ATPase function of
both enzymes is important for unwinding TNRs (Figure S2)
(Anand et al., 2012; Bhattacharyya and Lahue, 2004), consistent
with a requirement for helicase activity. These results support the
possibility that RTEL1 unwinds TNR hairpins before they can be
converted into full expansion mutations. Our genetic analysis
suggests that RTEL1 may work in the same pathway as HTLF
and Rad18, based on the requirement for Rad18 and HLTF in
expansion assays (Figures 3A and 3B), the double-knockdown
data of RTEL1+Rad18 and RTEL1+HLTF (Figure 2B), the similar
profiles of expansion sizes in all the knockdowns (Figure S2), and
the genetic complementation of Srs2’s role in the PRR pathway
(Figure 3). Thus, RTEL1 function at TNRs could act during post-
replication repair or a template-switching event such as fork
reversal (Figure 4).
In the PRR model, RTEL1 could unwind hairpins that initiate
PRR at gaps left behind the replication fork or hairpins that occur
during error-free PRR repair synthesis (Figure 4A). This model is
strengthened by the similarity of the D-loop structure (Figure 4A,
lower panel) to substrates that RTEL1 has been proposed to
unwind during recombination and at T-loops (Uringa et al.,
2011; Vannier et al., 2012). In this mode of action, RTEL1 could
antagonize error-prone recombination that leads to expansions
of long TNRs as seen in yeast (Kerrest et al., 2009; Sundararajan
et al., 2010). We postulate that RTEL1 is recruited to the TNR
by postreplication repair factors Rad18 and/or HLTF or that
these factors modify another target that in turn attracts RTEL1
(Figure 4A). The activity of all three proteins would remove the
hairpin and prevent expansions, whereas lack of RTEL1, HLTF,
or Rad18 would result in higher expansion frequencies.
Another potential mode of action is through HLTF-mediated,
error-free resolution of TNR replication stress (Figure 4B).
HLTF, like Rad5, mediates reversal of model stalled replication
forks by unwinding of the leading and lagging strands and
then annealing of the nascent and parental strands to form a
chicken-foot structure (Blastya´k et al., 2010). This raises the
possibility that replication fork reversal by HLTF could provide
a means for stabilizing TNR tracts. In this case, RTEL1 would un-
wind hairpins at a stalled or reversed fork to allow restart without
expansions or fragility. A hairpin on the reversed fork end was
previously proposed as a potential expansion intermediate
Figure 4. Models for Inhibition of Expan-
sions by the Concerted Activities of HLTF,
Rad18, and RTEL1
(A) A triplet repeat hairpin is formed by DNA repli-
cation (shown) or repair (not shown). HLTF and
Rad18 recruit RTEL1directly to thehairpin ormodify
another factor that does so. Once at the hairpin,
RTEL1uses itshelicaseactivity tounwind thehairpin
to help avoid an expansion. Lower panel: recom-
binational repair attempts to resolve the hairpin but
creates another hairpin in the process. RTEL1 acts
to resolve the hairpin(s) and avoid expansion.
(B) A hairpin is formed during DNA replication in
conjunction with fork stalling. The hairpin could be
alleviated directly by RTEL1 (top panel), or HLTF
in conjunction with Rad18 acts to reverse the
stalled fork, which brings RTEL1 to the hairpin for
unwinding.
Loss or reduced levels of HLTF, Rad18, or RTEL1
preclude hairpin unwinding such that the hairpin
is subsequently processed to a triplet repeat
expansion.(Mirkin, 2007) and provides a single-stranded DNA/double-
stranded DNA junction, proposed to be a good substrate for
RTEL1 loading and 50 to 30 unwinding (Uringa et al., 2011; Youds
et al., 2010). Similarly, a template switch at the fork, mediated by
HTLF and Rad18, could also require RTEL1 to unwind aberrant
structured intermediates that might occur (Kim and Mirkin,
2013; Mirkin, 2007). This unwinding activity of RTEL1 is sup-
ported by the facts that Srs2 excels at unwinding G-rich struc-
tured DNA encountered during replication (Anand et al., 2012)
and RTEL1 also appears to have in vivo roles in unwinding
G-rich or structured regions at telomeres and recombination
hot spots (Uringa et al., 2011; Vannier et al., 2012). The fork
restart model could also explain how the lack of RTEL1, HLTF,
or Rad18 would lead to excess expansions.
There is emerging evidence that RTEL1 andHLTF help prevent
human disease. Polymorphisms in the RTEL1 gene are suscep-
tibility loci for glioma risk (Shete et al., 2009; Wrensch et al.,
2009), and inherited mutations in RTEL1 cause a severe form
of dyskeratosis congenita (Ballew et al., 2013; Le Guen et al.,
2013; Walne et al., 2013). For HLTF, silencing of its promoter
by methylation is associated with colon, gastric, and uterine
cancers (Debauve et al., 2008; Moinova et al., 2002). Based on
our findings in this paper, we suggest that downregulation or
loss of RTEL1 or HLTF might also lead to genetic predisposition
toward TNR expansions.EXPERIMENTAL PROCEDURES
Expansion Assays, siRNA Treatment, and Expression Analysis
in SVG-A Cells
SVG-A astrocytes were cultured and assayed for expansions as described
previously (Gannon et al., 2012) and as summarized in Figure S1. Briefly, cells
were seeded on day 0 and transfected on day 1 with siRNA. On day 3, cells
were transfected with triplet repeat shuttle vector and also retransfected
with siRNA. After another 2 days, expansion frequencies were measured
(Gannon et al., 2012), in parallel with analysis of expression levels from
whole-cell lysates. The Supplemental Experimental Procedures provides
details regarding siRNA, PCR primers, and antibodies. Subsequent PCRanalysis of individual yeast colonies confirmed the number and size of TNR
expansions. Statistical details are given in Figure S1E.
RTEL1 Purification and Helicase Assays
Wild-type and K48R mutant RTEL1 were expressed as N-terminal fusions
to glutathione-S-transferase (GST) and expressed in Sf-9 cells using the
baculovirus expression system. Briefly, infected cells were lysed by sonicat-
ion, and protein was precipitated with ammonium sulfate and fractionated
by gel filtration. Fractions containing GST-tagged proteins were further puri-
fied with glutathione affinity chromatography, cleaved by protease digestion
of the tag, and concentrated. Details are given in the Supplemental Experi-
mental Procedures. The formation of labeled helicase substrates and the
helicase assays were carried out as described by Dhar and Lahue (2008).
Yeast Genetic Assays for Chromosome Fragility and Triplet Repeat
Instability
Strains (Figure S4A) were isogenic BY4705 background containing a yeast
artificial chromosomewith 0, 70, or 85 CAG,CTG repeats, with the CAG strand
on the lagging-strand template (Callahan et al., 2003; Sundararajan et al.,
2010). Mutants were created through PCR-mediated gene replacement to
generate srs2::Fbh1 and srs2::RTEL1 constructs. CAG tract length was tested
by PCR amplification and analyzed for expansions ±9 bp (three repeats).
Fragility and instability assays were performed as previously described (Kerr-
est et al., 2009). Two independent transformants were tested for each strain.
Spot assays were repeated twice independently with two different trans-
formants to test reproducibility. See the Supplemental Experimental Proce-
dures for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.01.034.
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